NUTRIBAND INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M | $2.1M | $2.1M | $2.1M | $1.4M | $943.7K | $370.6K | $245.3K |
| Cost of Revenue | $1.5M | $1.4M | $1.2M | $1.3M | $917.8K | $627.4K | $549.1K | $288.3K |
| Gross Profit | $566.3K | $743.3K | $862.1K | $750.4K | $554.3K | $316.2K | $-178.5K | $-43.0K |
| Gross Margin | 27.8% | 34.7% | 41.3% | 36.1% | 39.0% | 33.5% | -48.1% | -17.5% |
| Operating Expenses | ||||||||
| Research & Development | $1.9M | $3.1M | $2.0M | $982.2K | $411.4K | — | — | — |
| SG&A Expense | $7.0M | $4.3M | $3.8M | $3.9M | $4.0M | $2.9M | $1.8M | $3.3M |
| Operating Income | $-8.3M | $-10.3M | $-4.9M | $-4.5M | $-6.1M | $-2.6M | $-2.0M | $-3.3M |
| Operating Margin | -408.4% | -480.7% | -233.6% | -215.2% | -429.7% | -275.1% | -531.4% | -1,358.1% |
| Interest Expense | $22.5K | $21.4K | $75.8K | $8.3K | $118.4K | $280.7K | $73.4K | — |
| Pretax Income | $-8.2M | $-10.5M | $-5.5M | $-4.5M | $-6.2M | $-2.9M | $-2.7M | $-3.3M |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-8.2M | $-10.5M | $-5.5M | $-4.5M | $-6.2M | $-2.9M | $-2.7M | $-3.3M |
| Net Margin | -404.1% | -489.9% | -263.0% | -215.6% | -434.3% | -310.8% | -734.3% | -1,358.1% |
| EPS (Basic) | $-2.58 | $-0.99 | $-0.69 | $-0.53 | $-0.80 | $-0.51 | $-0.50 | $-0.62 |
| EPS (Diluted) | $-2.58 | $-0.99 | $-0.69 | $-0.53 | $-0.80 | $-0.51 | $-0.50 | $-0.62 |
| Shares Outstanding (Basic) | 11.6M | 10.6M | 8.0M | 8.5M | 7.9M | — | 5.5M | 21.7M |
| Shares Outstanding (Diluted) | 11.6M | 10.6M | 8.0M | 8.5M | 7.9M | 5.8M | 5.5M | 21.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |